This application note describes how the Centre for Eye Research Australia and the University of Melbourne optimized protocols for the maintenance and reprogramming of patient-derived fibroblast cells into induced pluripotent stem cells and their differentiation into retinal cells using the Freedom EVO liquid handling platform.
